These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: [A trial to produce an inactivated Lassa fever vaccine]. Author: Krasnianskiĭ VP, Potryvaeva NV, Borisevich IV, Gradoboev VN, Pashanina TP, Pshenichnov VA. Journal: Vopr Virusol; 1993; 38(6):276-9. PubMed ID: 8303891. Abstract: A single and double immunization of Papio hamadryas monkeys with an inactivated concentrated purified adsorbed preparation of Lassa virus in doses of 0.5-1.0 and 1.1-2.1 mg by protein, respectively, protected the animals against the development of the disease and occurrence of viremia after an intramuscular challenge with 0.4 PFU dose. Upon aerogenic infection of monkeys protection of 50% of the animals was achieved by a single immunization with the inactivated preparation in a dose 1.1 mg by protein.[Abstract] [Full Text] [Related] [New Search]